The Last Xigris® Survivor

被引：4

作者：

Barie, Philip S.

机构：

来源：

关键词：

CRITICAL SURGICAL ILLNESS; ACTIVATED PROTEIN-C; SEPTIC SHOCK; SEVERE SEPSIS; PROWESS-SHOCK; MORTALITY; TRIAL; PLAN;

D O I：

10.1089/sur.2011.9909

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：423 / 425

页数：3

共 19 条

[1] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
Abraham, E
Laterre, P
Garg, R
Levy, H
Talwar, D
Trzaskoma, BL
Francois, B
Guy, JS
Bruckmann, M
Rea-Neto, A
Rossaint, R
Perrotin, D
Sablotzki, A
Arkins, N
Utterback, BG
Macias, WL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341
[2] [Anonymous], SOURCE CONTROL
[3] Barie Philip S, 2007, Surg Infect (Larchmt), V8, P491, DOI 10.1089/sur.2007.9980
[4] Barie Philip S, 2005, Surg Infect (Larchmt), V6, P41, DOI 10.1089/sur.2005.6.41
[5] Efficacy of Therapy with Recombinant Human Activated Protein C of Critically Ill Surgical Patients with Infection Complicated by Septic Shock and Multiple Organ Dysfunction Syndrome
Barie, Philip S.
Hydo, Lynn J.
Shou, Jian
Eachempati, Soumitra R.
[J]. SURGICAL INFECTIONS, 2011, 12 (06) : 443 - 449
[6] Current role of activated protein C therapy for severe sepsis and septic shock
Barie P.S.
[J]. Current Infectious Disease Reports, 2008, 10 (5) : 368 - 376
[7] Barie Philip S, 2006, Surg Infect (Larchmt), V7, P485, DOI 10.1089/sur.2006.7.485
[8] BARIE PS, 1995, ARCH SURG-CHICAGO, V130, P77
[9] Efficacy and safety of recombinant human activated protein C for severe sepsis.
Bernard, GR
Vincent, JL
Laterre, P
LaRosa, SP
Dhainaut, JF
Lopez-Rodriguez, A
Steingrub, JS
Garber, GE
Helterbrand, JD
Ely, EW
Fisher, CJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
[10] Dellinger RP, 2008, CRIT CARE MED, V36, P1394